DTM
Abbott
Boston
Nevro
More DTM
100

Cathode Placement for A1

What is Mid 8

100
Abbott's battery is X times bigger than Intellis

What is 2-3 times bigger

100

Boston Responder Rate of 88% in Combo Study measured what

What is Overall Pain

100

Size of Nevro Senza Omnia battery

2 times that of Intellis

100

How glial cells contribute to chronic pain.

What is injured nerves release glutamate and Substance P, and they also send out distress signals which activate astrocytes and microglia. Activated glial cells can become dysfunctional, and when they don’t return to a normalized state, a chronic pain state exists. Then, the released substances from the activated glia increase sensitivity of pain sensing neurons (secondary neurons) which then become hyperactive.

200

For the three DTM groups to be available, what verterbal bodies must be spanned by the leads

What is Mid T8-Mid T10

200

Abbott Proclaim batteries cannot be scanned without

What is adjusting MR Machine and if a lead is fractured

200

Boston Sci Spectra WaveWriter SCS MRI access to Chest, Spine, Torso, Pevis, Heart and Breast

What is 0%

200

Reduced power needed to scan Nevro Senzo Omnia Perc leads

What is 80%

200

Elevator Pitch

Doctor, I want to discuss Medtronic's launch of a newly developed waveform called DTM SCS. This waveform proved superio to convential stim in a recent level1 RCT resulting in a high 80 percent responder rate in back pain alone.

DTM SCS is unique in that it is the first waveform to be inspired by by science and rooted in pre-clinical work prior to being proven in an RCT

Decades of basic science has led us to believe that glial cells are active contributors in chronic pain. to expand on that understanding, pre-clinical studies have shown us that DTM SCS modulates not just neurons, but also glial cells, which outnumber neurons 12:1 in the spinal cord.

We promote DTM SCS based on evidence.  This level 1 RCT is the evidence that DTM SCS proved superior to convential stimulation.  Proven only on the Intellis Platform with a proprietary algorithm, this is the science that matters.

Can we spend 5 minutes to review the Level 1 RCT and the results achieved using Intellis SCS with DTM SCS?

300

Tell me how to set amplitue for a prime signal

What is turn up perception, then back down until sensation is gone, then calculate 65% of that value

300

Role Play: Abbott superior due to not having to charge

What is your play

300
Boston battery takes x hours to charge from empty to full

What is 4 hours

300

Reduced power needed to scan surgical leads with Nevro Senza Omnia

What is 88%

300

Mean VAS reduction in back pain in the DTM RCT

What is 74%

400

The lead used to program group C

What is Caudal

400

Abbott Battery Warranty with Tonic Stimulation

What is warranty voided

400

Role Play Boston has superior responding rate

What is your role play?

400

Response from Medtronic rep is Doctor says Nevro can do DTM too

I am certain they will tell you they can do it. Afterall, these results are terrific. I am also certain they do not know how to do it. This is has been proven only on Intellis™ and with a proprietary algorithm. 

DTM™ SCS uses a precise proprietary algorithm that was designed for and is proven only on the Intellis™ platform in an RCT 2. Medtronic has acquired intellectual property rights, including a patent portfolio, for the novel DTM™ SCS therapy 3. DTM™ SCS’ specific programming was designed using a decade of proprietary preclinical research 4. This goes beyond even the specific programming parameters—it’s about the knowledge on how it’s delivered via the Intellis™ hardware 3) PIVOT THE CONVERSATION 1. DTM™ preclinical evidence 2. Intellis™ Features (Unrivaled SCS Platform) 3. DTM™ SCS RCT Data

400

Number of patients who had profound back pain relief (80% or more)

What is 63%

500

Elevator Pitch

Doctor, I want to discuss Medtronic's launch of a newly developed waveform called DTM SCS. This waveform proved superio to convential stim in a recent level1 RCT resulting in a high 80 percent responder rate in back pain alone.

DTM SCS is unique in that it is the first waveform to be inspired by by science and rooted in pre-clinical work prior to being proven in an RCT

Decades of basic science has led us to believe that glial cells are active contributors in chronic pain. to expand on that understanding, pre-clinical studies have shown us that DTM SCS modulates not just neurons, but also glial cells, which outnumber neurons 12:1 in the spinal cord.

We promote DTM SCS based on evidence.  This level 1 RCT is the evidence that DTM SCS proved superior to convential stimulation.  Proven only on the Intellis Platform with a proprietary algorithm, this is the science that matters.

Can we spend 5 minutes to review the Level 1 RCT and the results achieved using Intellis SCS with DTM SCS?

500

Responder Rate of Sunburst Study

What is 39%

500

Delta of responder rate in Combo Study compared to control arm

What is 17% ie 88%-71%

500

Nevro has the best in class 24 month data w/HF10™ vs 3 months.”

What is DTM™ SCS 3 month data is impressively strong, especially the profound pain relief.1 • We have presented superior results at 3 months and anticipate end points at 6 and 12 months to be presented in 2020. • Did you wait 24 months before trying HF10™?

Ask to consider the DTM™ SCS Challenge

500

How to set amplitude for a base signal

What is turn up to perception, then back off until perception is completely gone. Then multiply that value x .7, and that is your starting amplitude.

M
e
n
u